{"id":18110,"date":"2016-03-04T00:00:00","date_gmt":"2016-03-04T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/2016\/03\/04\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"modified":"2024-04-24T19:50:22","modified_gmt":"2024-04-24T19:50:22","slug":"eyewitness-report-fda-science-board-meets-on-opioid-crisis","status":"publish","type":"post","link":"https:\/\/www.cadca.org\/fr\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","title":{"rendered":"Rapport de t\u00e9moins oculaires\u00a0: Le conseil scientifique de la FDA se r\u00e9unit sur la crise des opio\u00efdes"},"content":{"rendered":"<p>Le nouvellement nomm\u00e9 <a href=\"https:\/\/www.fda.gov\/AboutFDA\/CommissionersPage\/default.htm\" target=\"_blank\" rel=\"noopener\">Commissaire de la FDA, Robert M. Califf, MD<\/a>., a fait de la lutte contre la crise des opio\u00efdes une priorit\u00e9. Le 4 f\u00e9vrier, alors que de nombreux membres de la CADCA terminaient leur formation au Forum national sur le leadership de la CADCA, le <a href=\"https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm484765.htm\" target=\"_blank\" rel=\"noopener\">La FDA a annonc\u00e9 un plan d&#039;action<\/a> pour r\u00e9\u00e9valuer l&#039;approche de l&#039;agence \u00e0 l&#039;\u00e9gard des m\u00e9dicaments opio\u00efdes.\u00a0<\/p>\n<p>Dans la foul\u00e9e de cette annonce radicale, la FDA a fix\u00e9 une r\u00e9union de son comit\u00e9 scientifique au 1er mars. Les objectifs de la discussion \u00e9taient les suivants : discuter du r\u00f4le des opio\u00efdes dans la gestion de la douleur ; envisager le d\u00e9veloppement de nouveaux m\u00e9dicaments pour traiter la douleur qui r\u00e9duisent les risques d&#039;abus\u00a0; et explorez le r\u00f4le que joue la FDA dans le cadre d&#039;une r\u00e9ponse f\u00e9d\u00e9rale, \u00e9tatique et locale plus large aux d\u00e9fis li\u00e9s \u00e0 la fourniture d&#039;un traitement appropri\u00e9 de la douleur tout en r\u00e9duisant l&#039;abus de m\u00e9dicaments opio\u00efdes sur ordonnance. Si vous \u00eates un peu passionn\u00e9 de politique, en voici quelques-unes. <a href=\"https:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/ScienceBoardtotheFoodandDrugAdministration\/ucm487037.htm\" target=\"_blank\" rel=\"noopener\">documents de r\u00e9f\u00e9rence<\/a> la FDA a compil\u00e9 que vous aimerez peut-\u00eatre lire.<\/p>\n<p>J&#039;ai \u00e9t\u00e9 t\u00e9moin oculaire de cette r\u00e9union. L\u2019une des grandes opportunit\u00e9s que nous avons \u00e0 CADCA est de repr\u00e9senter le terrain de la coalition dans des moments comme celui-ci. Il n\u2019est pas surprenant que la r\u00e9union d\u2019experts m\u00e9dicaux ait concentr\u00e9 l\u2019essentiel de son attention sur les solutions pharmacologiques. Il a \u00e9t\u00e9 d\u00e9clar\u00e9 que la FDA ne r\u00e9glemente pas la communaut\u00e9 m\u00e9dicale. Cependant, ils ont une influence consid\u00e9rable sur l&#039;\u00e9tiquetage, les nouveaux produits, les formations de dissuasion contre les abus et la strat\u00e9gie d&#039;\u00e9valuation et d&#039;att\u00e9nuation des risques (REMS), qui obligent les fabricants \u00e0 s&#039;assurer que les avantages d&#039;un m\u00e9dicament ou d&#039;un produit biologique l&#039;emportent sur ses risques.<\/p>\n<p>La premi\u00e8re partie de la journ\u00e9e a \u00e9t\u00e9 consacr\u00e9e aux pr\u00e9sentations de divers intervenants de haut niveau sur les politiques, la douleur, la d\u00e9pendance et les donn\u00e9es. Dans l&#039;apr\u00e8s-midi, un temps a \u00e9t\u00e9 r\u00e9serv\u00e9 aux commentaires du public. Pendant plus d&#039;une heure et demie, le comit\u00e9 scientifique et les dirigeants de la FDA ont entendu un large \u00e9ventail de citoyens am\u00e9ricains et, curieusement, un Fran\u00e7ais. Le plus poignant pour moi a \u00e9t\u00e9 la d\u00e9claration de Don Flattery, un p\u00e8re qui a perdu son fils de 27 ans \u00e0 cause d&#039;une maladie de d\u00e9pendance, et qui a soulign\u00e9 l&#039;exposition pr\u00e9coce de son fils aux opio\u00efdes \u00e0 la suite d&#039;une blessure sportive. La Commission a entendu une d\u00e9fenseure des patients souffrant d&#039;un trouble rare du tissu conjonctif qui a soulign\u00e9 la n\u00e9cessit\u00e9 d&#039;avoir acc\u00e8s aux opio\u00efdes afin de l&#039;aider dans son fonctionnement quotidien. Des commentaires ont \u00e9t\u00e9 entendus de la part de repr\u00e9sentants de l&#039;industrie, de d\u00e9fenseurs passionn\u00e9s (tant du c\u00f4t\u00e9 de la douleur que de la d\u00e9pendance), et m\u00eame d&#039;un fabricant d&#039;un dispositif m\u00e9dical promettant de distribuer en toute s\u00e9curit\u00e9 des doses d&#039;opio\u00efdes. La p\u00e9riode de commentaires publics a repr\u00e9sent\u00e9 un groupe d&#039;id\u00e9es tr\u00e8s diverses et a soulign\u00e9 la complexit\u00e9 des probl\u00e8mes auxquels nous sommes confront\u00e9s.<\/p>\n<p>\u00c0 Washington DC, il est rare de voir un s\u00e9nateur am\u00e9ricain au large du Capitole. J&#039;\u00e9tais donc ravi de voir que le s\u00e9nateur Joe Manchin de Virginie-Occidentale avait fait le voyage \u00e0 travers la ville pour partager un <a href=\"https:\/\/www.manchin.senate.gov\/public\/index.cfm\/press-releases?ID=22FCD76D-DF4A-4425-B858-79C88DCAEDD6\" target=\"_blank\" rel=\"noopener\">d\u00e9claration<\/a> \u00e9galement pendant la p\u00e9riode de commentaires publics.\u00a0<\/p>\n<p>Chaque jour, 44 personnes aux \u00c9tats-Unis meurent d&#039;une surdose d&#039;opiac\u00e9s sur ordonnance. Les d\u00e9fenseurs locaux de la CADCA ont agi, sans attendre. Les coalitions sensibilisent les jeunes et les parents aux risques, mobilisent les prescripteurs sur leurs pratiques, soutiennent les PDMP, organisent des journ\u00e9es de reprise avec les forces de l&#039;ordre, travaillent dans les \u00e9coles pour dispenser une \u00e9ducation \u00e0 la s\u00e9curit\u00e9 des m\u00e9dicaments et bien plus encore. Certains d\u00e9fis doivent \u00eatre relev\u00e9s au niveau des \u00c9tats et au niveau f\u00e9d\u00e9ral. La FDA poss\u00e8de \u00e0 la fois l\u2019autorit\u00e9 et les relations n\u00e9cessaires pour avoir un impact monumental. CADCA s&#039;engage \u00e0 suivre toutes les actions f\u00e9d\u00e9rales li\u00e9es \u00e0 notre crise des opio\u00efdes et \u00e0 maintenir le domaine \u00e0 jour.\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Le nouveau commissaire de la FDA, Robert M. Califf, MD, a fait de la crise des opio\u00efdes une priorit\u00e9. Le 4 f\u00e9vrier,<\/p>","protected":false},"author":23,"featured_media":2408,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[360],"tags":[221],"class_list":["post-18110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-public-health","tag-opioids"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA<\/title>\n<meta name=\"description\" content=\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/fr\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA\" \/>\n<meta property=\"og:description\" content=\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/fr\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-04T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-24T19:50:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"426\" \/>\n\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marianne Varkiani\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marianne Varkiani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"},\"author\":{\"name\":\"Marianne Varkiani\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\"},\"headline\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis\",\"datePublished\":\"2016-03-04T00:00:00+00:00\",\"dateModified\":\"2024-04-24T19:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"},\"wordCount\":575,\"image\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"keywords\":[\"opioids\"],\"articleSection\":[\"Public Health\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\",\"name\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"datePublished\":\"2016-03-04T00:00:00+00:00\",\"dateModified\":\"2024-04-24T19:50:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\"},\"description\":\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"width\":426,\"height\":320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\",\"name\":\"Marianne Varkiani\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/fr\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","og_locale":"fr_FR","og_type":"article","og_title":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","og_description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","og_url":"https:\/\/www.cadca.org\/fr\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","og_site_name":"CADCA","article_published_time":"2016-03-04T00:00:00+00:00","article_modified_time":"2024-04-24T19:50:22+00:00","og_image":[{"width":426,"height":320,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","type":"image\/jpeg"}],"author":"Marianne Varkiani","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Marianne Varkiani","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#article","isPartOf":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"author":{"name":"Marianne Varkiani","@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2"},"headline":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis","datePublished":"2016-03-04T00:00:00+00:00","dateModified":"2024-04-24T19:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"wordCount":575,"image":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","keywords":["opioids"],"articleSection":["Public Health"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","url":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","name":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"image":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","datePublished":"2016-03-04T00:00:00+00:00","dateModified":"2024-04-24T19:50:22+00:00","author":{"@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2"},"description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","breadcrumb":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage","url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","contentUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","width":426,"height":320},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2","name":"Marianne Varkiani"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/posts\/18110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/comments?post=18110"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/posts\/18110\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media\/2408"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media?parent=18110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/categories?post=18110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/tags?post=18110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}